PaperInhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts

Add time:08/28/2019    Source:sciencedirect.com

Cancer procoagulant (CP) is a cysteine proteinase from cancer cells that initiates blood coagulation. Members of two classes of unique and highly specific cysteine proteinase inhibitors, peptidyl diazomethyl ketones (PDK) and peptidyl sulfonium salts (PSS), were studied to determine whether or not they inhibited CP. The inhibitors did not impair the activity of the coagulation system. There was a differential inhibitory effect of the 6 PDK and 2 PSS inhibitors, influenced by the amino acid composition or sequence of the peptide moiety, that suggests differences in structural features of the active site of CP and papain. CP was inhibited by both classes of inhibitors.

We also recommend Trading Suppliers and Manufacturers of 1-(diazomethyl)-4-nitrobenzene (cas 19479-80-2). Pls Click Website Link as below: cas 19479-80-2 suppliers

Prev:Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity
Next:Synthesis and thermal rearrangement of 5-diazomethyl-1,2,3-triazoles)